Study highlighting importance of MTM featured in Forbes

NEW YORK — Low-risk patients were three times less likely to be admitted to a hospital when they received medication therapy management from a pharmacist, according to the findings of a recent study that was highlighted in Forbes magazine.

“Enhancing the quality of care for patients has always been the goal of health care providers, but the growing costs of Medicare and health care in general have put an even brighter spotlight on strategies to improve patient outcomes and reduce unnecessary costs," he said.

Zillich led a team of researchers who collaborated with the home health care organization Amedisys and pharmacists from Curant Health (formerly HealthStat Rx), who provided the MTM intervention.

The study, led by Purdue University, underscores the important role that pharmacists can play in helping patients improve health outcomes.

"We know that medication therapy management (MTM) improves adherence, improves outcomes and improves lives," stated Patrick Dunham, CEO of Curant Health, which provided the medication therapy management interventions. "Reducing hospital admissions for the lowest-risk patients in this study by 86% is another powerful proof point for the value of MTM and its capability to simultaneously reduce costs and improve care across the health care continuum."

The study followed 895 patients from 40 Amedisys home health care centers throughout the United States, with 415 receiving the intervention.


Login or Register to post a comment.